miophthalmology products

Ellex’s Tango Reflex Neo, incorporating proprietary SLT technology, delivers advanced energy control, a homogenous sharp-edged aiming beam and the industry’s fastest firing rate of up to 4Hz – four shots per second.* This is a capability that is being used every day by surgeons worldwide to visualise the trabecular meshwork in greater detail, and to perform procedures faster and with improved accuracy, delivering better patient outcomes – reliably, accurately, and safely. Impressively, the Visionix VX650 can be operated entirely remotely by a licensed clinician from anywhere, enabling improved accessibility to eye care for all patients.

In the time since its launch, developments to the HFA have sought to elevate the visual field-testing experience. The most recent iteration of the Humphrey Field Analyser, the HFA3, offers the SITA Faster 24-2 strategy, supporting up to a 50% decrease in testing times.* The HFA3 also includes guided progression analysis (GPA), allowing for the detection and assessment of changes in glaucoma progression using mixed SITA tests taken on any HFA instrument, including the HFA II. This allows for the maintenance of legacy data when upgrading from the HFA II to HFA3.

The monitoring of progression of disease in glaucoma requires accurate and reproducible measurements. The Glaucoma Module Premium Edition provides this through a comprehensive and personalised analysis utilising the proprietary Anatomic Positioning System (APS) with a series of unique scan patterns to assess the optic nerve head, the retinal nerve fibre layer, and the macular ganglion cell layer. These APS-based scan patterns are automatically matched to each eye’s unique anatomic landmarks and to the characteristics of fine anatomic structures relevant in glaucoma diagnostics.

The Miniject implant is made of proprietary Star material; a soft and flexible, medical-grade silicone. It has anti-fibrotic properties through its micro-pores, which enable bio-integration and a natural flow of fluid throughout the implant. Three-year follow-up results presented at the 2023 World Glaucoma Congress demonstrate sustained, meaningful, mean IOP reduction of 36%, with 42% of patients medicationfree. Mean epithelial cell density loss at three years was 9% (less than for cataract surgery at two years). 1

Scheimpflug-camera that takes over 4,300 images per second. Ensuring accurate intraocular pressure (IOP) measurement is crucial for detecting and monitoring glaucoma and its progression. It is known that corneal thickness and biomechanical properties can challenge IOP readings, however, the Corvis ST provides biomechanically corrected IOP (bIOP) for greater accuracy. The corneal biomechanical parameters provided by the Corvis ST device are also used for normal tension glaucoma screening in the new BGF (biomechanical glaucoma factor) display.